Proteomic and genomic analyses suggest the association of apolipoprotein C1 with abdominal aortic aneurysm

Proteomics - Clinical Applications

Volumn 8, Issue 9-10, 2014, Pages 762-772

  Moxon, Joseph V ^a   Liu, Dawei ^a   Moran, Corey S ^a   Crossman, David J ^b   Krishna, Smriti M ^a   Yonglitthipagon, Ponlapat ^c   Emeto, Theophilus I ^a   Morris, Dylan R ^a   Padula, Matthew P ^d   Mulvenna, Jason P ^c   Rush, Catherine M ^a   Golledge, Jonathan ^a,e  

^a JAMES COOK UNIVERSITY   (Australia)

^b THE UNIVERSITY OF AUCKLAND   (New Zealand)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^e TOWNSVILLE HOSPITAL   (Australia)

Author keywords

Abdominal aortic aneurysm; Apolipoprotein C1; Biomarker; Mouse model

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN C1; APOLIPOPROTEIN E; GELATINASE B; MESSENGER RNA; BIOLOGICAL MARKER;

ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; GENE EXPRESSION; GENE PRODUCT; GENOMICS; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MICROARRAY ANALYSIS; MORTALITY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; ULTRACENTRIFUGATION; ANIMAL; CONFOCAL MICROSCOPY; GENE EXPRESSION PROFILING; GENETICS; KNOCKOUT MOUSE; METABOLISM; TANDEM MASS SPECTROMETRY;

ANIMALS; AORTIC ANEURYSM, ABDOMINAL; APOLIPOPROTEIN C-I; APOLIPOPROTEINS E; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; GENE EXPRESSION PROFILING; MALE; MICE; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; TANDEM MASS SPECTROMETRY;

EID: 84908040599     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201300119     Document Type: Article

References (45)

1. Moxon, J. V., Parr, A., Emeto, T. I., Walker, P. et al., Diagnosis and monitoring of abdominal aortic aneurysm: current status and future prospects. Curr. Probl. Cardiol. 2010, 35, 512-548.
2. Golledge, J., Tsao, P. S., Dalman, R. L., Norman, P., Circulating markers of abdominal aortic aneurysm presence and progression. Circulation 2008, 118, 2382-2392.
3. Earnshaw, J. J., Triumphs and tribulations in a new national screening programme for abdominal aortic aneurysm. Acta Chir. Belg. 2012, 112, 108-110.
4. Ehlers, L., Overvad, K., Sørensen, J., Christensen, S. et al. Analysis of cost effectiveness of screening Danish men aged 65 for abdominal aortic aneurysm. Br. Med. J. 2009, 338, b2243.
5. Moxon, J. V., Padula, M. P., Clancy, P., Emeto, T. I. et al. Proteomic analysis of intra-arterial thrombus secretions reveals a negative association of clusterin and thrombospondin-1 with abdominal aortic aneurysm. Atherosclerosis 2011, 219, 432-439.
6. Moxon, J. V., Padula, M. P., Herbert, B. R., Golledge, J., Challenges, current status and future perspectives of proteomics in improving understanding, diagnosis and treatment of vascular disease. Eur. J. Vasc. Endovasc. Surg. 2009, 38, 346-355.
7. Trollope, A., Moxon, J. V., Moran, C. S., Golledge, J., Animal models of abdominal aortic aneurysm and their role in furthering management of human disease. Cardiovasc. Pathol. 2011, 20, 114-123.
8. Rush, C., Nyara, M., Moxon, J. V., Trollope, A. et al. Whole genome expression analysis within the angiotensin II-apolipoprotein E deficient mouse model of abdominal aortic aneurysm. BMC Genomics 2009, 10, 298.
9. Spin, J. M., Hsu, M., Azuma, J., Tedesco, M. M. et al. Transcriptional profiling and network analysis of the murine angiotensin II-induced abdominal aortic aneurysm. Physiol. Genomics 2011, 43, 993-1003.
10. Faca, V. M., Song, K. S., Wang, H., Zhang, Q. et al. A mouse to human search for plasma proteome changes associated with pancreatic tumour development. PLoS Med. 2008, 5, e123.
11. Jing, L., Parker, C. E., Seo, D., Hines, M. W. et al. Discovery of biomarker candidates for coronary artery disease from an ApoE-knockout mouse model using iTRAQ-based multiplex quantitative proteomics. Proteomics 2011, 11, 2763-2776.
12. -/- mouse model and allows the discovery of new candidate biomarkers in mouse and human atherosclerosis. Mol. Cell Proteomics 2012, 11, M111.013847.
13. von zur Muhlen, C., Schiffer, E., Zuerbig, P., Kellmann, M. et al., Evaluation of urine proteome pattern analysis for its potential to reflect coronary artery atherosclerosis in symptomatic patients. J. Proteome. Res. 2009, 8, 335-345.
14. Lenk, G. M., Tromp, G., Weinsheimer, S., Gatalica, Z. et al., Whole genome profiling reveals a significant role for immune function in human abdominal aortic aneurysms. BMC Genomics 2007, 8, 237
15. Dowling, P., Clynes, M., Conditioned media from cell lines: a complementary model to clinical specimens for the discovery of disease-specific biomarkers. Proteomics 2011, 11, 794-804.
16. Moxon, J. V., Flynn, R. J., Golden, O., Hamilton, J. V. et al., Immune responses directed at egg proteins during experimental infection with the liver fluke Fasciola hepatica. Parasite Immunol. 2010, 32, 111-124.
17. Unwin, R. D., Griffiths, J. R., Whetton, A. D., Simultaneous analysis of relative protein expression levels across multiple samples using iTRAQ isobaric tags with 2D nano LC-MS/MS. Nat. Protoc. 2010, 5, 1574-1582.
18. Aziz, A., Zhang, W., Li, J., Loukas, A. et al., Proteomic characterisation of Echinococcus granulosus hydatid cyst fluid from sheep, cattle and humans. J. Proteomics 2011, 74, 1560-1572.
19. Schwacke, J. H., Hill, E. G., Krug, E. L., Comte-Walters, S. et al., iQuantitator: a tool for protein expression inference using iTRAQ. BMC Bioinformatics 2009, 10, 342.
20. Emanuelsson, O., Brunak, S., von Heijne, G., Nielsen, H., Locating proteins in the cell using TargetP, SignalP and related tools. Nat. Protoc. 2007, 2, 953-971.
21. Duncan, D. T., Prodduturi, N., Zhang B., WebGestalt2: an updated and expanded version of the web-based gene set analysis toolkit. BMC Bioinformatics 2010, 11, 10.
22. Crossman, D. J., Ruygrok, P. N., Soeller, C., Cannell, M. B., Changes in the organization of excitation-contraction coupling structures in failing human heart. PLoS One 2011, 6, e17901.
23. Moran, C. S., Cullen, B., Campbell, J. H., Golledge, J., Interaction between angiotensin, I. I., osteoprotegerin, and peroxisome proliferator-activated receptor-gamma in abdominal aortic aneurysm. J. Vasc. Res. 2009 46, 209-217.
24. Gygi, S. P., Rochon, Y., Franza, B. R., Aebersold, R., Correlation between protein and mRNA abundance in yeast. Mol. Cell Biol. 1999, 19, 1720-1730.
25. Hellenthal, F. A., Buurman, W. A., Wodzig, W. K., Schurink, G. W., Biomarkers of AAA progression. Part 1: extracellular matrix degeneration. Nat. Rev. Cardiol. 2009, 6, 464-474.
26. Moxon, J. V., Liu, D., Wong, G., Behl-Gilhotra, R. et al., Comparison of the serum lipidome in patients with abdominal aortic aneurysm and peripheral artery disease. Circ. Cardiovasc. Genet. 2014, 7, 71-79.
27. Meikle, P. J., Wong, G., Tsorotes, D., Barlow, C. K. et al., Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 2723-2732.
28. Jong, M. C., Hofker, M. H., Havekes, L. M., Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2 and ApoC3. Arterioscler. Thromb. Vasc. Biol. 1999, 19, 472-484.
29. Westerterp, M., de Haan, W., Berbée, J. F., Havekes, L. M. et al., Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL. J. Lipid Res. 2006 47, 1203-1211.
30. Westerterp, M., Van Eck, M., de Haan, W., Offerman, E. H. et al., Apolipoprotein CI aggravates atherosclerosis development in ApoE-knockout mice despite mediating cholesterol efflux from macrophages. Atherosclerosis 2007, 195, e9-e16.
31. Saraff, K., Babamusta, F., Cassis, L. A., Daugherty, A., Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2003, 23, 1621-1626.
32. Moran, C. S., Jose, R., Moxon, J. V., Roomberg, A. et al., Everolimus limits aortic aneurysm in the apolipoprotein E deficient (ApoE-/-) mouse by down-regulating CCR2+ monocytes. Arterioscler. Thromb. Vasc. Biol. 2013, 33, 814-821.
33. Takigawa, M., Yoshimuta, T., Akustu, K., Takeshita, S. et al., Prevalence and predictors of coexistent silent atherosclerotic cardiovascular disease in patients with abdominal aortic aneurysm without previous sympotmatic cardiovascular diseases. Angiology 2012, 63, 380-385.
34. Gopal, K., Nagarajan, P., Jedy, J., Raj, A. T. et al., β-Carotene attenuates angiotensin II-induced aortic aneurysm by alleviating macrophage recruitment in ApoE-/- mice. PLoS One 2013, 8, e67098.
35. Getz, G. S., Reardon, C. A., Animal models of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2012, 32, 1104-1115.
36. Li, X., Liu, Y., Zhang, H., Liming, R. et al., Animal models for the atherosclerosis research: a review. Protein Cell. 2011, 2, 189-201.
37. Golledge, J., Norman, P. E., Atherosclerosis and abdominal aortic aneurysm: cause, response, or common risk factors? Arterioscler. Thromb. Vasc. Biol. 2010, 30, 1075-1077.
38. Dejouvencel, T., Feron, D., Rossignol, P., Sapoval, M. et al., Hemorphin 7 reflects hemoglobin proteolysis in abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 2010, 30, 269-275.
39. Golledge, J., Muller, R., Clancy, P., McCann, M. et al., Evaluation of the diagnostic and prognostic value of plasma D-dimer for abdominal aortic aneurysm. Eur. Heart J. 2011, 32, 354-364.
40. Reissner, K. J., Uys, J. D., Schwacke, J. H., Comte-Walters, S. et al., AKAP signaling in reinstated cocaine seeking revealed by iTRAQ proteomic analysis. J. Neurosci. 2011, 31, 5648-5658.
41. Bewley, M. A., Pham, T. K., Marriott, H. M., Noirel, J. et al., Proteomic evaluation and validation of cathepsin D regulated proteins in macrophages exposed to Streptococcus pneumoniae. Mol. Cell. Proteomics 2011, 10, M111.008193.
42. Krishna, S. M., Seto, S. W., Moxon, J. V., Rush, C. et al., Fenofibrate increases high density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model. Am. J. Pathol. 2012, 181, 706-718.
43. Huang, Y., Zhang, X., Jiang, W., Wang, Y. et al., Discovery of serum biomarkers implicated in the onset and progression of serous ovarian cancer in a rat model using iTRAQ technique. Eur. J. Obstet. Gynecol. Reprod. Biol. 2012, 165, 96-103.
44. Chang, C. T., Liao, H. Y., Chang, C. M., Chen, C. Y. et al., Oxidized ApoC1 on MALDI-TOF and glycated-ApoA1 band on gradient gel as potential diagnostic tools for atherosclerotic vascular disease. Clin. Chim. Acta 2013, 420, 69-75.
45. Rezeli, M., Vegvari, A., Donnarumma, F., Gidlof, O. et al., Development of an MRM assay panel with application to biobank samples from patients with myocardial infarction. J. Proteomics 2013, 87, 16-25.